Table 3.
Summary of the checklist for measuring quality of study reporting.
| Studies | Clear Description of the Hypothesis, Objectives | Outcomes Clearly Described in the Introduction or Methods Section | Clear Description of the Patient’s Characteristics | Clear Description of Intervention of Interest | Clear Description of the Distribution of Principal Confounders | Clear Description of Study Findings | Estimates of the Random Variability in the Data for the Outcomes | Measurement of Adverse Events | Description of Patient’s Characteristics that were Lost to Follow-Up | Report of Probability Values | Score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| [22] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [27] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [32] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 6/10 |
| [24] | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1/10 |
| [13] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 6/10 |
| [23] | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 4/10 |
| [33] | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 6/10 |
| [21] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [34] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [29] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [20] | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 6/10 |
| [31] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [28] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [30] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [35] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [26] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [36] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [37] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |
| [25] | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 7/10 |